Pharmacogenetics of pediatric acute lymphoblastic leukemia in Uruguay: adverse events related to induction phase drugs

In Uruguay, the pediatric acute lymphoblastic leukemia (ALL) cure rate is 82.2%, similar to those reported in developed countries. However, many patients suffer adverse effects that could be attributed, in part, to genetic variability. This study aims to identify genetic variants related to drugs ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Burgueño-Rodríguez, Gabriela, Méndez, Yessika, Olano, Natalia, Schelotto, Magdalena, Castillo, Luis, Soler, Ana María, da Luz, Julio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690766/
https://www.ncbi.nlm.nih.gov/pubmed/38044950
http://dx.doi.org/10.3389/fphar.2023.1278769

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690766/
https://www.ncbi.nlm.nih.gov/pubmed/38044950
http://dx.doi.org/10.3389/fphar.2023.1278769

Ejemplares similares